HRT Financial LP's Form 4 filing
Tenon Medical, Inc. (TNON) · filed Sep 11, 2026
- Accession no.
- 0001475597-26-000240
- Filed
- Sep 11, 2026, 2:13 PM ET
- Trade date
- Sep 8-10, 2026
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions. Open-market purchases total $383.0K. Open-market sales total $538.6K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| HRT Financial LPCIK 0001475597 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Common Stock | PPurchaseAcquired | +707 | $3.34F1 | +$2,361.38 | 2,653 | Direct | |
| Sep 9, 2026 | Common Stock | SSaleDisposed | −50,395 | $2.61F1 | −$131,530.95 | 18,182 | Direct | |
| Sep 9, 2026 | Common Stock | PPurchaseAcquired | +39,508 | $3.40F1 | +$134,327.2 | 18,182 | Direct | |
| Sep 9, 2026 | Common Stock | SSaleDisposed | −9,948 | $4.27F1 | −$42,477.96 | 18,182 | Direct | |
| Sep 10, 2026 | Common Stock | PPurchaseAcquired | +31,227 | $2.92F1 | +$91,182.84 | 15,839 | Direct | |
| Sep 10, 2026 | Common Stock | PPurchaseAcquired | +28,267 | $4.02F1 | +$113,633.34 | 15,839 | Direct | |
| Sep 10, 2026 | Common Stock | PPurchaseAcquired | +8,431 | $4.92F1 | +$41,480.52 | 15,839 | Direct | |
| Sep 10, 2026 | Common Stock | SSaleDisposed | −65,582 | $5.56F1 | −$364,635.92 | 15,839 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 8 transactions in Table I.